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Effectiveness of hypnosis for pain 
management and promotion 
of health-related quality-of-life 
among people with haemophilia: a 
randomised controlled pilot trial
Ana Cristina Paredes1,2, Patrício Costa1,2,3, Susana Fernandes4, Manuela Lopes4, 
Manuela Carvalho4, Armando Almeida1,2 & Patrícia Ribeiro Pinto1,2
Joint deterioration and associated chronic pain are common among people with haemophilia (PWH), 
having an impact on quality-of-life. Though non-pharmacological strategies are recommended, 
psychological interventions to promote pain control and quality-of-life have scarcely been tested 
in haemophilia. This randomised controlled pilot trial aimed to assess feasibility, acceptability and 
effectiveness of hypnosis for pain management and promotion of health-related quality-of-life (HRQoL) 
among PWH. Twenty adults were randomised either to four weekly hypnosis sessions plus treatment-
as-usual (experimental group; EG) or treatment-as-usual only (control group; CG). Participants 
completed sociodemographic and clinical assessment, measures of pain, HRQoL and emotional distress 
before (T1) and after (T2) intervention. Changes were analysed by calculating the differences between 
T1 and T2, and the groups were compared through independent-sample t tests (or chi-squared). 
Retention rates (90%) and analysis of patient satisfaction showed good acceptability and feasibility 
of the intervention. The EG (n = 8) had a higher reduction on pain interference than the CG (n = 10) 
(d = −0.267). A higher improvement on HRQoL (EQ-5D index: d = 0.334; EQ-5D VAS: d = 1.437) and 
a tendency towards better haemophilia-related quality-of-life (A36-Hemofilia QoL) were also evident 
in the EG. This is the first study showing the effectiveness of hypnosis to reduce pain interference and 
promote HRQoL among PWH.
Haemophilia is an X-linked rare bleeding disorder, resulting from a deficiency in blood coagulation factor VIII 
(haemophilia A) or IX (haemophilia B), and characterized by a pattern of spontaneous bleeding episodes that 
most often occur in the muscles (haematomas) or joints (haemarthrosis)1. The frequency of spontaneous bleeds 
is associated with disease severity, which is classified according to plasma levels of clotting factor activity (severe: 
<1% of normal factor level; moderate: 1 to 5%; mild: 5 to 40%)2. Intravenous administration of factor replace-
ment concentrate is the mainstay of treatment, delivered to stop bleeds (on-demand) or to prevent its occurrence 
(prophylaxis)3. Prophylaxis can potentially prevent bleeds altogether, but its use as a routine treatment since 
childhood has only been considered a standard of care during the last two decades. As a consequence, most adults 
with severe haemophilia did not benefit from prophylaxis while growing up and are now afflicted with some 
degree of joint damage, due to frequent haemarthrosis and lifelong accumulation of intraarticular blood4.
Haemarthrosis are painful events that, if repeated, progressively contribute to the development of chronic hae-
mophilic arthropathy, characterized by irreversible joint damage, disability and chronic pain5. Pain is therefore a 
very relevant issue among people with haemophilia (PWH), with studies reporting a prevalence of chronic pain 
ranging from 35 to 66%6–9, and about half the participants in some investigations complaining of daily arthritic 
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pain10,11. In addition, it has been demonstrated that PWH who experience more intense or frequent pain have 
lower quality-of-life8,10,12,13, further highlighting the unquestionable relevance of an adequate pain management 
in this field. Yet, haemophilia-related pain is still under-recognized and suboptimally treated14,15, and several 
authors have called on the need to improve its assessment and management, advocating for a combination of 
pharmacological and non-pharmacological techniques7,16,17.
Besides clinical variables (e.g. bleeding rate, joint status, pain), health-related quality-of-life (HRQoL) is a val-
uable outcome of research to capture patients perspective on their health. This is even more relevant in such bur-
densome conditions like haemophilia, with lifelong complications and demanding treatments18. Indeed, research 
on this topic has shown that PWH have lower HRQoL than the general population12,19–21. This has contributed to 
current haemophilia guidelines, which emphasize quality-of-life promotion as a relevant endpoint of comprehen-
sive care22. However, the few interventional studies assessing HRQoL outcomes among adult PWH have mainly 
focused on the effects of physical exercise and physiotherapy interventions23,24, or on the impact of different factor 
replacement treatment modalities25,26. To our knowledge, the efficacy of psychological interventions specifically 
aiming at improving pain management and quality-of-life among PWH has never been tested, leaving a signifi-
cant gap in evidence-based treatments targeting these outcomes.
The existing research focusing on psychological interventions among PWH is outdated and has focused 
mainly on hypnosis, showing positive results for disease management27–29. Indeed, the medical use of hypnosis 
is approved since 1955 by the British Medical Association30 and is recognized as an effective intervention to help 
manage chronic pain31, also contributing to improve HRQoL across distinct medical fields32–34. In haemophilia, 
the promising results that have been reported using hypnosis make the discontinuity of this line of research some-
what surprising, and thus encourage the development of investigations to further explore its usefulness.
The aim of this work was to assess the effectiveness of a hypnosis intervention for pain management and 
promotion of HRQoL among people with haemophilia. Since this is a rare disease, with an estimated number of 
700 cases in Portugal35, we conducted a pilot trial to address if a future randomised controlled trial (RCT), with a 
larger sample, would be feasible and well-accepted by patients.
Results
Feasibility and acceptability. Patient screening and assessment (pre and post-intervention) occurred from 
January to June 2018. The flow of patients through the study, reasons for ineligibility and refusals are shown in 
Fig. 1. Thirty-five adult patients with haemophilia were identified as eligible. Of these, 20 accepted to participate 
and met the inclusion criteria, and were therefore randomised to one of the study groups. One participant from 
the CG was excluded because he underwent orthopaedic surgery during the duration of the trial, and one par-
ticipant in the EG dropped out of the intervention after one session due to unavailability to attend the remaining 
sessions. Another participant who had been initially allocated to the EG also expressed unavailability to attend the 
intervention sessions, but was willing to change to the CG. Thus, the final analysed sample included 8 participants 
in the EG and 10 participants in the CG.
Retention rate in the pilot trial was 90%, with participants in the EG (n = 8) attending all hypnosis sessions. 
Concerning satisfaction with intervention, 2 (25%) participants in the EG revealed to be “satisfied” and 6 (75%) 
“very satisfied” with the intervention. All participants (8, 100%) stated they felt “a lot” better after the four ses-
sions, said they “agree” that these interventions would be useful in haemophilia centres and also “agree” that they 
would wish to participate in further sessions, if available.
No unanticipated harm or detrimental effects of intervention were reported.
Sociodemographic and clinical characteristics. Baseline sociodemographic and clinical participant 
characteristics are summarized in Table 1. The groups were not statistically different on any of these variables, 
although a large effect size (ES) was found for the differences on age (d = −0.879) and number of affected joints 
(d = −0.985); and a medium ES for the number of painful locations (d = −0.770).
No statistically significant differences were found between the groups at baseline on the analysed outcomes, 
except on the “treatment difficulties” subscale of the A36 Hemofilia-QoL (t(16) = 2.52; p = 0.023; d = 1.27) (results 
not shown). This subscale score revealed higher difficulties for the EG.
Comparison of pre/post-intervention changes among groups. Table 2 shows the differences from 
baseline to post-intervention in each outcome for each group, comparing them. Concerning work absences, the 
number of days missed from work in the previous month decreased in the EG (Δ = 5.80 days; SD = 13.57) and 
had a slight increase in the CG (Δ = −0.83; SD = 2.04), corresponding to a medium ES (d = −0.656).
Regarding the clinical parameters under assessment, pain interference yielded significant results (d = −0.267), 
decreasing in both groups, but with a higher reduction in the EG (Δ = 0.75; SD = 1.53) than in the CG (Δ = 0.41; 
SD = 0.99). The differences on pain intensity from pre to post intervention were not significant (d = 0.195) 
between the groups.
In what concerns general HRQoL, there was a statistically significant difference between groups on EQ-5D 
VAS (t(16) = 3.03, p = 0.008, d = 1.437), with a mean 13.75 (SD = 10.94) point improvement in the EG and a mean 
7.50 (SD = 17.20) decrease in the CG. EQ-5D index scores increased in both groups, yet with a slightly higher 
improvement in the EG (small ES, d = 0.334). Concerning haemophilia-related quality-of-life, the EG revealed 
a global tendency towards better HRQoL at post-intervention, with a higher difference (larger improvements) 
than the CG on the global score (ES = 0.335) and in 4 of the 9 specific dimensions. The higher effect sizes for 
these improvements in the EG were found on “treatment difficulties” (large ES, d = 0.852) and “daily activities” 
(medium ES, d = 0.581). Despite having small effect sizes, “physical health” (d = 0.296) and “joints” (d = 0.297) 
also yielded higher improvements in the EG, compared with the CG. Finally, the magnitude of the differences 
concerning depression and anxiety was not significant (depression, d = 0.097; anxiety, d = 0.009).
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Discussion
This manuscript reports a randomised controlled pilot trial aiming to assess the feasibility, acceptability and effec-
tiveness of a hypnosis intervention among people with haemophilia (PWH). Findings revealed, for the first time, 
the specific benefits of hypnosis in diminishing pain interference and in improving health-related quality-of-life 
(HRQoL) among PWH.
Important practical insights were also retrieved from this study, namely concerning the feasibility of a future 
randomized controlled trial (RCT). Considering the rarity of this disease and the inclusion criteria for partici-
pation, the main challenge in implementing a future RCT would be the recruitment of a big enough sample size 
to guarantee statistical power. In this case, implementing a multi-centre trial could be a potential solution. From 
this pilot study, it also became clear that time availability to participate in the intervention sessions is a relevant 
constraint, particularly for participants who have a full-time occupation. In this sense, it seems that accounting 
for individual allocation preferences could be advantageous to guarantee bigger sample sizes, namely by adopting 
patient preference designs. In these, participants with a strong preference for one of the arms are assigned to it, 
while the others are randomised between the groups. This approach contributes to improve recruitment rates 
and is more advantageous when active involvement of patients is warranted, without compromising internal and 
external validity36,37.
Globally, this study showed that it is feasible to develop and implement an RCT with PWH that is based on 
hypnosis. The participants in the experimental group (EG) attended all sessions (except one person that discon-
tinued the intervention after the first session and was thus excluded from the study), demonstrating good accepta-
bility of the intervention. All participants reported to be satisfied with the intervention and expressed the wish to 
keep attending, if more sessions were available.
Former studies have previously reported the implementation of hypnosis among PWH, with positive results 
in controlling bleeding, reducing pain and alleviating stress27–29. Other investigations, describing imagery and 
relaxation techniques similar to hypnosis, have also achieved reductions in arthritic pain for PWH undergoing 
intervention38,39. These were encouraging results for the use of hypnosis as an adjunctive strategy for haemophilia 
care, but the fact that most conclusions were based on case studies and lacked a rigorous methodology warrants 
further research to establish more definitive conclusions40. Surprisingly, the last reports of studies analysing the 
Figure 1. Flowchart of study participants.
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efficacy of hypnosis in the haemophilia field date from the early 90’s. To our knowledge, no more recent research 
was conducted on this subject, hence the relevance of further exploring this issue.
Previous research has described reductions on pain intensity following hypnosis across a variety of other 
chronic pain conditions41–48. Nevertheless, and despite the good results yielded by the present study on pain inter-
ference, similar improvements on pain intensity were not found. One possible explanation for this result might be 
the long duration of pain within this sample of patients. As far as we are aware, there are no studies investigating 
hypnosis effectiveness among patients with such a long pain duration as in this pilot trial, with around 70% of the 
participants having pain for over 20 years. In the literature reviewed on this subject, the highest mean pain dura-
tion identified was 13 years47. This is particularly significant since continuous and prolonged painful inputs from 
the damaged joints may cause an amplification of the responses of peripheral nociceptors (peripheral sensitiza-
tion) and central nervous system neurons (central sensitization), resulting in an over activation of the nociceptive 
system49. Indeed, central and peripheral sensitization have been demonstrated in PWH17, and since the level of 
sensitization is dependent on pain duration50, these phenomenon may help to understand the non-significant 
changes in pain intensity found in the present study. In addition to physiological mechanisms, cognitive and 
emotional factors could also help explain the results, as these also play an important role in pain modulation51. 
Future trials with adequate sample sizes should therefore control for the potential moderator effect of psycholog-
ical variables on intervention outcomes.
Additionally to a very long pain duration, it is possible that 4 sessions of hypnosis might have been insufficient 
to produce a significant decrease on pain intensity. Although some studies have achieved positive results with 
only 3 or 4 sessions41,42,45, most chronic pain trials include more sessions. It is true that brief interventions have 
been proven effective in conditions such as surgical acute pain52, but it is likely that the specificities of chronic 
pain demand a higher number of sessions. For example, Tan et al.43 showed that 2 self-hypnosis training sessions 
were effective in reducing pain intensity and interference, but these were followed by six weekly reminder tele-
phone calls that possibly accounted for the positive results. Indeed, it has been recommended that a full hypnosis 
treatment should comprise 8 or more sessions53, and the question of the ideal number of sessions to achieve a 
clinically significant improvement in symptoms should be further analysed in future studies. Lastly, and given the 
low sample size, it is also important to consider the contribution of individual results for the group averages54. In 
this scope, it should be noted that one participant in the hypnosis sessions had a fall during the treatment period, 
with a later X-ray revealing a displacement of his knee prosthesis, which understandably influenced pain intensity 
ratings increase between pre and post-test.
Though pain intensity is traditionally the most valued outcome of pain research, it is also important to analyse 
the effects of treatments on other pain-related outcomes, to shed a more comprehensive light over the burden 
of pain48. Corroborating other reports42,43, the current study suggests that hypnosis intervention is effective in 
decreasing the perception of pain interference. Though there was a reduction on pain interference in both groups, 
it was higher in the EG, accounting for a significant effect size. The relevance of this finding is underscored by 









(n = 8) t/χ2 (df) p d/ϕ
Sociodemographic
Age 45.00 (9.48) 41.70 (10.41) 49.13 (6.62) −1.748 (16) 0.100 −0.879
Education (≥12 
years) 9 (50%) 5 (50%) 4 (50%) 0.000 (1) 1.00 0.000
Marital status 
(married) 12 (66.7%) 7 (70%) 5 (62.5%) 0.113 (1) 0.737 0.079
Prof. status 
(employed) 11 (61.1%) 6 (60%) 5 (65.5%) 0.012 (1) 0.914 0.026
Clinical
Haemophilia A 15 (83.3%) 9 (90%) 5 (75%) 0.720 (1) 0.396 0.200
Severe haemophiliaa 14 (77.8%) 7 (70%) 7 (87.5%) 0.787 (1) 0.375 0.209
Prophylaxis 7 (38.9%) 4 (40%) 3 (37.5%) 0.012 (1) 0.914 0.026
Inhibitors 2 (11.1%) 0 2 (25%) 2.813 (1) 0.094 0.395
Bleeds last month 
(yes) 8 (44.4%) 3 (30%) 5 (62.5%) 1.901 (16) 0.168 0.325
Number of affected 
joints 5.44 (2.99) 4.30 (2.83) 6.88 (2.696) −1.958 (16) 0.068 −0.985
Target jointb 13 (72.2%) 7 (70%) 6 (75%) 0.055 (1) 0.814 0.055
Pain
Duration ≥20 years 13 (72.2%) 7 (70%) 6 (75%) 0.055 (1) 0.814 0.055
Painful locations 
last year 4.11 (1.97) 3.50 (1.58) 4.88 (2.23) −1.531 (16) 0.145 −0.770
Table 1. Characteristics of study participants and differences between groups at baseline. Note: Continuous 
variables are presented as mean (standard deviation) and categorical variables are presented as n (%). aSevere: 
factor level < 1% of normal, Moderate: factor level 1 to 5% of normal2. bThree or more spontaneous bleeds into a 
single joint within a consecutive 6-month period2.
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patients with chronic pain8. Indeed, pain has been associated with lower HRQoL among PWH8,10,12,13, yielding 
a global negative impact on daily life. For instance, an international survey reported that as much as 89% of the 
participants had pain that interfered with daily activities12, mainly on physical functioning domains, but also 
having an impact on mood and enjoyment of life55. Congruently, previous findings of our team have shown that 
the greatest pain interference reported by Portuguese PWH was on dimensions related to daily activities, such as 
work and mobility, but also on mood13. In this scope, a positive association between pain interference and distress 
was also found among PWH, heightening the relevance of interventions that target pain interference in this popu-
lation56. This body of evidence and our current findings add to recent publications calling for an improvement on 
pain management among PWH, namely through a broader adoption of non-pharmacological strategies7,14,16,17. 
Given the acknowledged negative impact of pain and these recent calls to improve its management in the haemo-
philia field, we would advocate for an urgent shift on research, from collection of observational data towards the 
implementation and testing of pain management interventions.
Notwithstanding the encouraging results showing reductions on pain interference, the most notable findings 
from this intervention concern HRQoL. In this sample, baseline EQ-5D VAS scores were lower (worse percep-
tion of health status) than those described in other haemophilia studies8,20,25. However, the effect of age has to be 
considered when comparing these figures, since those studies included data from younger samples (mean ages 
ranging from 29.7 to 37 years old). Research has indeed demonstrated that HRQoL scores tend to be lower among 
older PWH12,19,57, which has been at least partially explained by increased joint deterioration in this age group19,57. 
Congruent data was found in the present sample, with participants in the EG having a higher mean age and more 
affected joints. Nonetheless, these participants had a higher increase in EQ-5D index scores than those in the CG 
and an unequivocal improved assessment of their overall health status (EQ-5D VAS) at post-test, with partici-
pants in the CG even presenting a reduction in EQ-5D VAS scores. This is even more noteworthy considering the 
older mean age of participants in the EG, suggesting that hypnosis is an effective way to improve the subjective 
evaluation of health, even among older PWH who present more joint deterioration.
Concerning haemophilia-related quality-of-life, the improvements were higher for the EG on most dimen-
sions, with the largest effect sizes on global HRQoL, “daily activities”, “treatment difficulties”, “physical health” 
and “joints”. These data show a more marked benefit of the intervention on dimensions related to the percep-
tion of physical health, which indeed tends to be more affected in PWH, comparing to mental health dimen-
sions21,55. In this scope, it is also relevant to note that there were no significant reductions on “pain” scores (A36 













M (SD) t (df) p d
No. missed work days 
(last month)a 0 0.83 (2.04) 7.00 (13.04) 1.2 (1.79) −0.833 (2.04) 5.80 (13.57) −1.083 (4) 0.338 −0.656
No. bleeds last month 0.90 (1.91) 1.20 (1.40) 1.25 (1.17) 1.50 (1.69) −0.30 (1.42) −0.25 (1.83) −0.065 (16) 0.949 −0.031
Pain intensity 4.27 (1.77) 3.81 (1.51) 4.22 (1.99) 4.13 (1.09) 0.46 (2.11) 0.09 (1.48) 0.412 (16) 0.686 0.195
Pain interference 3.05 (1.58) 2.64 (1.72) 3.96 (2.62) 3.21 (2.30) 0.41 (0.99) 0.75 (1.53) −0.563 (16) 0.581 −0.267
EQ-5D-5L: VAS 62.5 (13.99) 55.00 (13.33) 56.25 (21.17) 70.00 (18.89) 7.50 (17.20) −13.75 (10.94) 3.029 (16) 0.008 1.437
EQ-5D-5L: Index score 0.70 (0.08) 0.74 (0.08) 0.58 (0.23) 0.68 (0.09) −0.04 (0.12) −0.09 (1.48) 0.703 (16) 0.492 0.334
A36 Hemofilia-QoL: 
global score 99.7 (13.06) 108.9 (13.83) 92.38 (28.25) 107.13 (23.27) −9.20 (8.87) −14.75 (20.78) 0.706 (9) 0.498 0.335
Physical health [0–32] 19.90 (2.52) 21.80 (4.29) 18.75 (6.88) 22.38 (4.63) −1.90 (5.20) −3.63 (6.55) 0.624 (16) 0.541 0.296
Daily activities [0–16] 10.00 (3.59) 12.40 (3.63) 7.38 (6.23) 12.38 (4.07) −2.40 (3.47) −5.00 (5.50) 1.225 (16) 0.238 0.581
Joints [0–12] 7.50 (2.17) 6.90 (1.85) 6.88 (1.73) 7.00 (3.16) 0.60 (2.32) −0.13 (2.59) 0.626 (16) 0.540 0.297
Pain [0–8] 4.30 (2.11) 5.20 (1.40) 4.50 (1.07) 5.13 (1.36) −0.90 (2.28) −0.63 (2.07) −0.265 (16) 0.795 −0.126
Treatment satisfaction 
[0–8] 6.40 (1.58) 6.60 (1.08) 6.88 (1.13) 6.75 (0.89) −0.20 (1.23) 0.13 (0.99) −0.606 (16) 0.553 −0.288
Treatment difficulties 
[0–16] 14.60 (1.58) 13.70 (3.16) 11.28 (3.85) 12.75 (2.38) 0.90 (2.88) −1.50 (2.73) 1.797 (16) 0.091 0.852
Emotional functioning 
[0–20] 12.20 (3.55) 15.90 (2.89) 13.13 (4.91) 15.50 (3.21) −3.70 (2.95) −2.38 (4.34) −0.771 (16) 0.452 −0.366
Mental health [0–12] 8.50 (2.55) 9.20 (2.20) 8.00 (3.21) 8.50 (3.78) −0.70 (3.83) −0.50 (1.60) −0.138 (16) 0.892 −0.066
Relationships and social 
activity [0–20] 16.30 (2.91) 17.20 (1.62) 15.63 (5.29) 16.75 (6.32) −0.90 (2.77) −1.13 (3.27) 0.158 (16) 0.876 0.075
HADS: Depression 0.60 (1.07) 0.50 (0.71) 1.50 (3.85) 1.50 (3.85) 0.10 (1.29) 0 (0.53) 0.205 (16) 0.840 0.097
HADS: Anxiety 3.50 (2.88) 3.60 (2.55) 3.38 (2.56) 3.50 (3.16) −0.10 (2.99) −0.13 (2.42) 0.019 (16) 0.985 0.009
Table 2. Baseline and post-intervention scores, and results of the independent samples t test for pre/post-
intervention differences (Δ) between study groups. aOnly assessed among employed participants (CG: n = 6; 
EG: n = 5). Note: Possible score ranges for each of the A36 Hemofilia-QoL subscales are specified in square 
brackets. Abbreviations: VAS, Visual Analogue Scale; HADS, Hospital Anxiety and Depression Scale. Bold font 
indicates an effect size >0.20.
6Scientific RepoRtS |         (2019) 9:13399  | https://doi.org/10.1038/s41598-019-49827-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Hemofilia-Qol). However, the 2 items composing this subscale refer only to pain frequency, which was not a 
specific target of the intervention sessions. Therefore, no changes were expected in this dimension.
As outlined in the introduction section, there are no published controlled trials specifically aiming to test 
psychological interventions that promote HRQoL among adult PWH, despite the acknowledgment that it is 
impaired in these patients12,19–21. Only one of the former reports of hypnosis in haemophilia makes a reference 
to quality-of-life, affirming that it is improved among patients using self-hypnosis, though it is not clear whether 
it was formally assessed29. Despite the absence of interventional studies with PWH, some comparisons can be 
drawn from investigations analysing the utility of hypnosis in other conditions that, like haemophilia, are asso-
ciated with disabling symptoms. Corroborating the findings from this paper, those have shown that hypnosis is 
effective in improving HRQoL among patients with irritable bowel syndrome32, fibromyalgia33 and breast can-
cer34. This body of evidence further supports the utility of hypnosis to promote HRQoL and favours the pursuit 
of this line of research, encouraging the adoption of strategies that can improve the well-being, and thus the 
quality-of-life, of patients with chronic conditions.
Lastly, it is also relevant to note that the present results revealed a reduction in work absences in the EG, which 
could be related to the significant findings concerning global pain interference. Also, fewer missed days from 
work could be associated with the improved perception of HRQoL among participants in the EG.
This investigation has some limitations to consider. Although this was a pilot study, the small sample size hin-
ders the establishment of definitive conclusions concerning the effectiveness of the intervention, which should 
be overcome in a future, adequately powered RCT. Additionally, specific measures should be adopted to avoid 
treatment contamination between the groups (i.e. the possibility that participants in the EG may disseminate 
information concerning the intervention to participants in the CG). However, the significant effect sizes obtained 
indicate treatment effectiveness and cannot be dismissed as a promising research direction58. In addition, the 
demographic and clinical differences between groups at baseline may have influenced the outcomes. Namely, 
patients in the EG have more affected joints and more painful locations which, as discussed above, can impact 
HRQoL and pain experience. Similarly, it would also be relevant to consider the role of other clinical variables, 
such as prophylaxis status or inhibitor development, and to control for their influence on the studied outcomes.
Another important variable to account for in a future RCT would be hypnotic susceptibility, since it has been 
suggested that highly susceptible individuals derive increased benefits from hypnotic pain interventions59. In this 
scope, it might be plausible that hypnotic susceptibility levels could at some degree account for the lack of a signif-
icant decrease on pain intensity levels in this study. However, it has also been argued that, in clinical settings, the 
success or failure of hypnotic interventions is not dependent on hypnotisability, which would only explain a small 
percentage of variance in outcomes60. Studies with chronic pain patients have reached inconsistent conclusions 
on this matter, with some findings revealing increased reductions on pain intensity scores among highly suscep-
tible individuals46, others concluding that susceptibility was not related to outcomes43–45,48, and one study even 
reporting an inverse relationship between hypnotic susceptibility and reduction on pain intensity42. Undoubtedly, 
the inconsistent findings on this matter54,60 and the potential impact of hypnotic susceptibility on intervention 
outcomes justify the need to consider its inclusion as a potential moderator, or as a criteria for group stratification, 
in hypnotic intervention studies58.
Another suggestion for further studies would be a thorough record of self-hypnosis teaching and home prac-
tice, as a possible mean to explain clinically significant changes and long-term results. Also relevant to consider is 
the inclusion of an active control group besides the treatment-as-usual condition (e.g. attention group, relaxation 
training), in order to compare the relative efficacy of hypnosis and to rule out placebo effects as an explanation 
for the results obtained.
In conclusion, this pilot trial showed that it would be feasible to conduct an RCT to analyse the effectiveness 
of a hypnosis intervention among PWH. This was, to our knowledge, the first study suggesting that hypnosis is 
effective in decreasing pain interference and in improving the perception of HRQoL among PWH, providing a 
promising research direction that should be replicated with larger sample sizes and more homogenous groups, in 
order to establish more definitive conclusions.
Methods
Design. This was a two-arm randomised controlled pilot trial, with one experimental (intervention) group 
(EG) and one control group (CG), and three assessment moments: baseline (before intervention), post-test (after 
intervention) and 3 months after intervention. This manuscript reports the results from baseline (T1) and post-
test (T2) assessment moments.
This investigation was approved by the Portuguese National Data Protection Agency, the Life Sciences 
and Health Ethics Subcommittee (University of Minho) and the Ethics Committee from São João University 
Hospital Centre —E.P.E.. All procedures were carried out in accordance with the Declaration of Helsinki and 
relevant guidelines for clinical research with human participants, and reported following the Consolidated 
Standards of Reporting Trials (CONSORT). This pilot trial is part of a larger study, registered at clinicaltrials.gov 
(NCT02870452) on August 17th, 2016.
Participants. Participants were recruited from the European Haemophilia Comprehensive Care Centre 
(EUHANET certified centre) and Reference Centre for Congenital Coagulopathies (certified by the Portuguese 
Health Ministry) at São João University Hospital Centre, Porto, Portugal. Eligible patients were identified and 
approached by the clinicians of the haemophilia centre to be referred to the investigators, who made a later tele-
phone call for a more comprehensive evaluation of inclusion criteria. These included (a) male gender; (b) age ≥18 
years; (c) moderate or severe haemophilia A or B, with or without inhibitors; (d) chronic pain (as defined by the 
European Haemophilia Therapy Standardisation Board7; and (e) ability to consent voluntary participation to the 
study. The exclusion criteria were (a) severe and debilitating neurological conditions (e.g., dementia); (b) severe 
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organic or psychiatric conditions (e.g., cancer, schizophrenia); (c) undergoing any form of psychotherapy at time 
of enrolment; (d) having had orthopaedic surgery less than six months before study start or having it scheduled 
for the following six months; and e) unavailability to commit to four weekly intervention sessions.
During a visit to the haemophilia centre, participants signed the informed consent, performed baseline assess-
ment and were randomly allocated either to intervention or control group. At this time, the four weekly inter-
vention sessions were scheduled for participants in EG. Five weeks after baseline all participants completed the 
post-test assessment.
Since this was a pilot study, a formal sample size calculation was not performed.
Hypnotic intervention. Patients in the EG attended four consecutive weekly individual 60-min hypnotic 
sessions while maintaining treatment-as-usual. The hypnotic scripts were adapted from different sources61–65 and 
the intervention was conducted verbatim by one of the authors (PRP), who is a PhD Clinical Health Psychologist 
with certified advanced training in clinical hypnosis.
In order to engage patients in hypnosis, the first step is to explain its principles, providing patients with a 
rationale for its learning and use. In all sessions, theoretical-educative contents were provided and discussed 
before hypnotic induction. These focused on pain education, namely through the use of metaphors based on 
the gate control theory, emphasizing that pain results from a complex and dynamic interplay between biological 
processes and psychological factors (cognitive and emotional), as well as on contents regarding the relaxation 
response.
The hypnosis sessions comprised the following stages: (1) introduction/preparation of the patient (explaining 
the rationale underlying hypnosis, including dispelling potential myths, misconceptions and doubts; this step 
only in the first session); (2) hypnotic induction (suggestions to promote a state of relaxation and focused aware-
ness); (3) deepening procedure (further suggestions for achieving a more deeply relaxed and focused state); (4) 
symptom-specific therapeutic suggestions (specific for haemophilia, aiming to change or improve symptoms and/
or maladaptive behaviors, such as pain); (5) posthypnotic suggestions (to extend the benefits obtained beyond 
the session setting) and, finally (6) “waking up” the patient. On the first session, all the patients were taught 
self-hypnosis61 in order to be provided with means to perform hypnosis independently by themselves, thus rein-
forcing the posthypnotic suggestions. Self-hypnosis constitutes a powerful resource that guarantees the practice 
of the technique, independently and in an autonomous fashion, thereby empowering patients and giving them a 
sense of control and mastery over their problems and their lives53,63.
Regarding the hypnotic scripts, these consisted of an initial standardized hypnotic induction procedure 
(“Hartland’s Progressive Relaxation”)64, embracing suggestions to eye closure, concentration on breathing and 
promotion of a state of relaxation and focused awareness. It was then followed by the deepening procedure enti-
tled “Special-Place Deepening Technique”65. This technique was directed to the selection of a comfortable and 
peaceful place, according to the personal preference of each participant (e.g. beach, garden, an autobiographical 
event…), wherein patients are suggested to experience several sensorial details of the place, along with allusions 
to safety and control. After induction and deepening procedures, specific hypnotic techniques were administered. 
In the first session, the “Healing White Light”64 technique was used to promote natural healing of the body against 
haemophilia usual symptoms (swellings, bleeds, bodily pains), intending to induce a general sense of well-being 
and health fitness. In the remaining three sessions, the “Pain Switch” technique, along with “Direct Therapeutic 
Suggestions For Pain Control” were employed61. All sessions included the “Ego Strengthening Technique”, which 
is potentially powerful because it increases the patients’ ability to access inner resources, improving their stress 
management skills and fostering a sense of control over the illness65. All suggestions were made on a repetitive 
basis at each session and all sessions ended with post-hypnotic suggestions before waking up the patient. These 
underscored that any experience of well-being, healing and comfort obtained would remain with the patient and 
last beyond the sessions, becoming a permanent part of how the patient lives and copes with disease and prob-
lematic issues.
An overview of the sessions, with further description of the techniques, is in Table 3.
Control group. Patients in the control group received medical treatments and standard care as usual, with 
the assessments being made in the same time points as the intervention group, but without receiving any psycho-
logical intervention.
Outcomes and data collection. Feasibility and acceptability were evaluated by analysis of recruitment and 
retention rates, adherence to study protocol, and satisfaction with the intervention. The latter was assessed using 
four questions specifically developed for this study. These ask about overall satisfaction with the intervention 
(rated from 1 = very dissatisfied to 5 = very satisfied), perception of improvement in well-being after attending 
the four sessions (rated from 1 = nothing to 5 = totally), perception of the utility of this type of interventions in 
haemophilia centres and desire to participate in further sessions (both rated from 1 = disagree to 3 = agree).
To evaluate the effectiveness of the intervention, the following primary outcomes were considered: pain experi-
ence (intensity and interference) and HRQoL. To ensure the quality of self-reported data and avoid inter-assessor 
subjectivity, all assessments were performed in-person, by the same investigator, using the Portuguese version of 
the following measures:
•	 Socio-demographic and clinical questionnaire: Collects sociodemographic (e.g. age, education, employment) 
and haemophilia-related information (e.g. type and severity, bleeding episodes, treatment regimen).
•	 Multidimensional Haemophilia Pain Questionnaire (MHPQ)66: Assesses haemophilia-related pain, focusing 
on painful locations, duration, frequency, triggering factors, intensity, interference, strategies for pain con-
trol, pain specialists and satisfaction with treatment. Pain intensity [Cronbach’s alpha (α) = 0.65] is assessed 
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SESSION I
Introduction/Preparation of the patient
Explanation of the rationale underlying hypnosis, including dispelling potential myths, misconceptions and doubts.
Theoretical-Educative Contents
Pain Education: using the Gate Control Theory of pain, by Melzack and Wall (1965)
Transmission of information to educate patients about the subjectivity and multidimensionality of pain experience, conceptualizing 
it as the result of a dynamic and complex integration and interaction of psychological, biological and social dimensions. Emphasis on 
psychological factors as playing a critical role in pain experience, thus providing patients with a rationale for the importance of undergoing 
hypnosis, in order to become active resourceful agents, capable of self-managing their symptoms.
Rationale underlying the Relaxation and the Stress Response
Explaining the relaxation response as a psychophysiological state opposite to the fight-or-flight response, characterized by the reduction 
of sympathetic/HPA activities and increases in the parasympathetic tone, neutralizing the excessive stress and inflammation. Focus on the 




Suggestions to eyes closure, concentration on breathing, promoting a state of relaxation and focused awareness, imagining oneself as being 
in an agreeable and comfortable place. Patients are asked to relax their muscles one by one (feet, calves, thighs, stomach, chest, back, neck, 
shoulders, arms, forearms, hands, eyebrows, eyes, jaw) and to be aware of proprioceptive and interoceptive sensations.
2.2. Deepening Procedure
Special-Place Deepening Technique
Use of a metaphor of “descending a staircase” to help patients feel more deeply relaxed and hypnotized, by counting down from 10 
to 1, which leads to a comfortable place according to the individual preference of each participant (e.g. beach, garden, playing, an 
autobiographical event…). Perceptions of colours, shapes, sounds, smells and kinaesthetic sensations are integrated into the suggestions, 
in order to make use of as many sensorial modalities as possible. Suggestions of feelings of calm, safety, peace of mind and inner strengths 
are given and associated with the image of being in the comfortable place.
2.3. Therapeutic Suggestions
The Healing White Light
The patient is given suggestions to imagine a white light that is fiery and growing, moving around the body in order to induce a general 
sense of well-being and foster the process of healing. A special emphasis is placed on the joints more prone to hemarthrosis. It is intended 
to give the patient a sense of control over the illness as the white light travels through the body, infusing every part, eliminating the toxins 
and wastes, while returning a sense of purification and good health to the body. The script ends with a very positive note, emphasizing 
words such as vitality and energy, encouraging and giving hope to the patient (e.g. “…and now…I want you to bring the sphere of white 
light…the powerful white light to your joints …allow the white light to settle in your joint ankles… knees…in your joint hips… elbows… 
and… it sends rays of healing white light…all over your joints…enclosing…enveloping your joints in a blanket of healing white light…a nice 
healing therapeutic warmth…and…the rays of healing white light spreads…all over your body…you feel the warm energy…flowing in your 
body…rays of energy flowing out from the sphere of white light…).
Ego Strengthening Technique
Aims to infuse the patient with a sense of competency, to enhance individual coping skills and to empower the belief in personal 
capabilities, activating deep internal healing powers. Develops the ability to access inner resources and activate internal survival 
mechanisms, aiming to increase confidence, self-esteem and self-efficacy. Promotes stress management skills as well as coping with 
haemophilia symptoms and constraints. This strategy builds up strength and resiliency, by reminding the patients of their strength, their 
ability to take control, and that taking control is their major strength (e.g. “… feeling so good about how in control you are… of your body… 
your health… your life.”).
2.4. Post-Hypnotic Suggestions
Aims to anchor the suggestions provided during the sessions, highlighting that any positive responses occurring during hypnosis should 
last beyond the session and become “permanent and automatic” (e.g. “All benefits and skills that you have obtained from the session today…
can become… more and more… a permanent part of how your brain works…what your brain is learning, and to the extent that it brings you 
comfort and a greater sense of control, then, is becoming more and more a permanent part of who you are… of how your brain works.”).
3. Teaching Self-Hypnosis
The patient is instructed and taught to practice hypnosis on his own (e.g. Whenever you wish to use hypnosis for yourself… all you need to 
do is find a comfortable place where you can sit or lie down, close your eyes and consciously relax your body… Each time you use your self-
hypnosis, you will find yourself becoming more relaxed and calm in everyday situations.”).
4. Waking up
By counting upwards from 1 to 10, the patient is instructed to become increasing alert and to open the eyes (e.g. “… when you open your 
eyes, you will be fully alert, fully oriented to your surroundings, and ready to carry on with the rest of the day. Any normal feelings, such as a 
bit of stiffness or tiredness, will quickly pass once you have taken a deep breath and had a good stretch, and you will find that you will feel the 
benefits of relaxing like this for the rest of the day, feeling alert, relaxed and refreshed. So, I’ll now count upwards: 1… 2… 3… 4… 5… 6… 




2.1. Hypnotic Induction: “Hartland’s Progressive Relaxation”
2.2. Deepening Procedure: “Special-Place Deepening Technique”
2.3. Therapeutic Suggestions
The Pain Switch
Informs patient about how the brain is the boss and the controller of the body, as everything is controlled by it. The patient is instructed 
to travel to the Brain’s Control Centre and visualize the “pain switch” (e.g. “Your unconscious mind can also help you visualize this pain 
reception area, perhaps as a compartment or a master control room. When there is a lot of pain being reported there… you have a rheostat, a 
dimmer switch, which you can turn down… and experience less and less pain.”). Make the patient see the nerve connection from the brain to 
the body area that is painful. Using out breath to begin turning the switch down with each breath and continue until the pain is low enough 
(e.g.”Perhaps you will even want to rate it on a scale of 1 to 10, with 10 being the most pain that you would ever be in. And the number that 
you feel will be the number you can see in your mind and in this pain reception area…”). The switch is then locked in that position (e.g. “…so 
that you remain more comfortable and know you can help yourself in this way whenever you need.”).
Continued
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for six triggers/situations: bleeding episodes; during physical efforts and/or movement; using stairs; after 
resting or staying still; during rest, sitting or lying down; and accidental or “wrong” movements. Interference 
(α = 0.82) is rated in 7 domains, using the Brief Pain Inventory subscale67 (general activity, mood, walking 
ability, normal work, relations with others, sleep and enjoyment of life). Pain intensity and interference items 
are rated on a numerical rating scale, ranging from 0 (no pain/no interference) to 10 (worst imaginable pain/
completely interferes), with a mean score being computed for each scale.
•	 EQ-5D-5L68: Participants rate their overall HRQoL on five dimensions (mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression) according to a five level scale (1 = no problems; 5 = extreme prob-
lems), with a summary index being calculated for each participant (range: 0–1; where 1 is the best possible 
score) (α = 0.58). Overall health status is evaluated by patients on a 0–100 visual analogic scale (VAS), with 
higher scores indicating a better health status.
•	 A36 Hemofilia-QoL69: This is a disease-specific measure to assess haemophilia-related quality-of-life. The 36 
items are rated on a 5 point Likert scale, generating a global HRQoL score (possible range: 0–144; α = 0.90) 
and nine subscale scores (physical health, daily activities, joints, pain, treatment satisfaction, treatment dif-
ficulties, emotional functioning, mental health and relationships and social activity). Higher scores translate 
better HRQoL.
•	 Hospital Anxiety and Depression Scale (HADS)70: Used to evaluate emotional distress, according to two 
separate anxiety (α = 0.61) and depression (α = 0.92) scores (ranging from 0–21). Items are rated on a 4 point 
Likert scale (0–3), with higher results translating more symptomatology, and a score >8 being indicative of 
clinically significant symptoms71.
Randomisation. Participants were randomly allocated to intervention or control group (1:1 ratio), with the 
different randomisation steps being performed independently by two investigators. The randomisation sequence 
was computer-generated and concealed until official patient enrolment, after consenting to participate and per-
forming baseline assessment. Due to the differences in procedure, blinding of the patients to intervention versus 
control group was impossible. The clinicians from the haemophilia centre and the investigator performing the 
assessments were blind to patient allocation.
Data analysis. Data analyses were performed using IBM SPSS Statistics version 23 (Chicago, IL, USA). 
Participants’ characteristics are expressed as absolute and relative frequencies (n, %) for categorical data or mean 
and standard deviation (SD) for continuous variables.
To adjust for between-group baseline differences, changes from pre to post-test assessment were analysed by 
calculating the difference between the two moments (Δ = T1 score-T2 score). The normality assumption of the Δ 
variables was checked for the two groups (CG and EG) through Shapiro-Wilk test. Normality was guaranteed for 
all variables, except for “number of bleeds” and “missed work days” in both groups; and for the “joints”, “pain” and 
“relationships and social activity” subscales of the A36 Hemofilia QoL, in the EG. For these cases, the correspond-
ing non-parametric tests were used, and since the results were concordant with the corresponding parametric 
procedures, we decided to report the latter.
Direct Therapeutic Suggestions For Pain Control
Suggestions to change the pain transmission system using the Gate Control Theory of pain as a metaphor (e.g. “… Your unconscious mind 
can relax all the nerves and muscle fibres in the area of your body where there is tension or pain… It can also interrupt the pathways which 
travel from the site of the injury, to the spinal cord… into the pain reception area. There are many, many gates which these pain impulses must 
pass through, and your unconscious mind can close many of these gates, reducing the number of nerve impulses that will finally reach the pain 
reception area, and so, you simply will be aware of less pain… Your brain is now sending messages to the gate-control stations to tune down the 
intensity and quality of the pain signals, so that you will feel less and less discomfort…”).
Suggestions to control or change pain perception, by providing a specific set of skills, such as relaxation, that could be used to alter how the 
brain processes pain information thus promoting pain relief (e.g. “…as you allow yourself to go deeper and deeper, you are realizing, perhaps 
for the first time, that you can allow yourself to take control over your body through your mind. You can become more relaxed and with this 
relaxation your body’s healing mechanisms can function appropriately and normally. And as your body responds in this deeply relaxed way, 
you are becoming aware that you can permit yourself, when needed, to take greater control over your body than you ever thought possible. You 
are acquiring confidence in yourself… You are now in a relaxed state… An individual who is in such a relaxation state as you are does not feel 




SESSION III & IV
1. Theoretical-Educative Contents
2. Hypnotic Techniques
2.1. Hypnotic Induction: “Hartland’s Progressive Relaxation”
2.2. Deepening Procedure: “Special-Place Deepening Technique”
2.3. Therapeutic Suggestions: “Pain Switch”, “Direct Therapeutic Suggestions for Pain Control” and “Ego Strengthening Technique”
2.4. Post-Hypnotic Suggestions
3. Waking up
Table 3. Overview of the hypnosis sessions and brief description of the techniques. Adapted from Hammond61, 
Jensen62,63, Heap & Aravind64 and Frederick & McNeal65.
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The groups were compared through chi-squared tests (χ2, for categorical variables) or independent-sample t 
tests (for continuous variables), accounting for the equality of variances (Levene’s test). If the variances were not 
homogeneous, the Welch’s correction was used. Statistical significance was set at p < 0.05.
Since null hypothesis significance testing and, consequently, p values, depend on sample size, the meaning-
fulness of differences was determined through the associated effect sizes (ES). These were expressed as Cohen’s 
d for continuous variables and Pearson’s phi (ϕ) coefficient for nominal variables. Cohen’s d score above 0.80 is 
considered a large effect, between 0.50 and 0.80 a medium effect and between 0.20 and 0.49 a small effect72. The 
interpretation of Pearson’s phi (ϕ) coefficient is analogous to the correlation coefficient, expressing the strength of 
association between two variables. The internal consistency of responses to the questionnaires was assessed using 
the Cronbach’s alpha coefficient (α)73.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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